Budipine HCl
Budipine, also known as BY-701 and Parkinsan, is a non-dopaminergic antiparkinsonian drug. The primary action of budipine is an indirect dopaminergic effect as shown by facilitation of dopamine (DA) release, inhibition of monoamine oxidase type B (MAO-B) and of DA (re) up-take and stimulation of aromatic L-amino acid decarboxylase (AADC), which in sum might be responsible for enhancing the endogenous dopaminergic activity.
| Supplier | Ace Therapeutics |
|---|---|
| Product # | SMD708 |
| CAS # | 63661-61-0 (HCl) |
| Pricing | Customizable size, Inquiry |
| Synonym | Budipine Hydrochloride; BY-701; BY 701; BY701; Parkinsan |
| Product Category | Lab-use Small Molecule Drugs |
| Chemical Formula | C21H28ClN |
| Molecular Weight | 329.912 |
| Elemental Analysis | C, 76.45; H, 8.56; Cl, 10.75; N, 4.25 |
| IUPAC/Chemical Name | 1-(tert-butyl)-4,4-diphenylpiperidin-1-ium chloride |
| InChi Key | USUUKNCFNKZGEY-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C21H27N.ClH/c1-20(2,3)22-16-14-21(15-17-22,18-10-6-4-7-11-18)19-12-8-5-9-13-19;/h4-13H,14-17H2,1-3H3;1H |
| SMILES Code | CC([NH+]1CCC(C2=CC=CC=C2)(C3=CC=CC=C3)CC1)(C)C.[Cl-] |
| Appearance | Solid powder |
| Purity | >98% (or refer to the Certificate of Analysis) |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| Storage Condition | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO |
| Shelf Life | >2 years if stored properly |
| Drug Formulation | This drug may be formulated in DMSO |
| Stock Solution Storage | 0 - 4℃ for short term (days to weeks), or -20℃ for long term (months). |
| HS Tariff Code | 2934.99.9001 |